Introduction Neurological complications among hospitalized COVID‐19 patients may be
associated with elevated neurodegenerative biomarkers. Methods Among hospitalized …

Background Understanding the long-term effects of coronavirus disease 2019 (COVID-19)
on cognitive function is essential for monitoring the cognitive decline in the elderly …

SARS‐CoV‐2 infection can damage the nervous system with multiple neurological
manifestations described. However, there is limited understanding of the mechanisms …

Background This study examined neuropathological findings of patients who died following
hospitalization in an intensive care unit with SARS-CoV-2. Methods Data originate from 20 …

Background and Objectives Although patients hospitalized with COVID-19 frequently
present with encephalopathy, those with mild initial COVID-19 disease who never required …

The actual role of SARS‐CoV‐2 in brain damage remains controversial due to lack of
matched controls. We aim to highlight to what extent is neuropathology determined by SARS …

As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae
following COVID-19 recovery. Mechanisms to explain long-term neurological sequelae are …

Background and purpose Neurological symptoms have been frequently reported in
hospitalized patients with coronavirus disease 2019 (COVID‐19), and biomarkers of central …

The association between SARS‐CoV‐2 infection with increased risk for new‐onset
neurodegenerative diseases remains unclear. Therefore, this meta‐analysis aims to …

Since patients with Alzheimer's disease are at higher risk for hospitalization and death in the
setting of COVID-19, additional precautions and protective measures should be put in place …